Case Series: Recovery of Chemotherapy-Related Acute Heart Failure by the Combined Use of Sacubitril Valsartan and Wearable Cardioverter Defibrillator: A Novel Winning Combination in Cardio-Oncology

Effective anticancer treatments have dramatically improved the outcome of patients with cancer, but cardiac toxicity reduces their clinical efficacy in a non-negligible percentage of patients. Sacubitril/valsartan is a new paradigm in the treatment of chronic heart failure, with a reduced ejection f...

Descripción completa

Detalles Bibliográficos
Autores principales: Canale, Maria Laura, Coviello, Katia, Solarino, Gianluca, Del Meglio, Jacopo, Simonetti, Federico, Venturini, Elio, Camerini, Andrea, Maurea, Nicola, Bisceglia, Irma, Tessa, Carlo, Casolo, Giancarlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923038/
https://www.ncbi.nlm.nih.gov/pubmed/35299980
http://dx.doi.org/10.3389/fcvm.2022.801143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923038/
https://www.ncbi.nlm.nih.gov/pubmed/35299980
http://dx.doi.org/10.3389/fcvm.2022.801143

Ejemplares similares